Cergutuzumab
Cergutuzumab is a fully human IgG1 antibody that targets CEACAM5. The isotype control for Cergutuzumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
CAS Number
[1622305-37-6]
UNSPSC
12352203
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
98.86
Smiles
[Cergutuzumab]
Molecular Weight
(145.595 kDa)
References & Citations
[1]Flisikowska T, et al. A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies. Nat Biomed Eng. 2022 Nov;6 (11) :1248-1256.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1216290-01 0.02 mg (E-Coli)
Recombinant Burkholderia mallei Histidine--tRNA ligase (hisS)
Ask
View Details MBS1216290-02 0.02 mg (Yeast)
Recombinant Burkholderia mallei Histidine--tRNA ligase (hisS)
Ask
View Details MBS1216290-03 0.1 mg (E-Coli)
Recombinant Burkholderia mallei Histidine--tRNA ligase (hisS)
Ask
View Details 
MBS1216290-04 0.1 mg (Yeast)
Recombinant Burkholderia mallei Histidine--tRNA ligase (hisS)
Ask
View Details MBS1216290-05 0.02 mg (Baculovirus)
Recombinant Burkholderia mallei Histidine--tRNA ligase (hisS)
Ask
View Details